SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Mini DNA Replicator Could Benefit World’s Poor
May 2, 2007
 · 
1 min read
Lone Star Bio
Cheaper, Potentially Better Disease Treatments Expected from Faster Approach to Developing Therapeutic Antibodies, University of Texas Study
April 19, 2007
 · 
1 min read
Lone Star Bio
Chromosomes Tell Tale of Patient’s Risk for New, Future Cancer
April 17, 2007
 · 
1 min read
Lone Star Bio
Texas A&M University Physicists Unite With Princeton University To Develop Anthrax Detection Method
April 13, 2007
 · 
1 min read
Lone Star Bio
Genes Control Chemotherapy Impact, University of Texas Southwestern Medical Center Researchers Find
April 12, 2007
 · 
1 min read
Business
Pharma-Biotech Industry 2Q07 Forecast: Value of Project Construction Starts Increases 5% to $4.3 Billion
April 9, 2007
 · 
1 min read
Lone Star Bio
LabNow Rides Bumpy Road to Success
April 2, 2007
 · 
1 min read
Lone Star Bio
Top 10 Pharma-Biotech Projects to Inject $2 Bllion Capital Investment for 2007
March 27, 2007
 · 
1 min read
Lone Star Bio
University of Texas Southwestern Medical Center: Gene Controlling Circadian Rhythms May be Involved in Onset of Bipolar Disorder
March 23, 2007
 · 
1 min read
Lone Star Bio
Protein Found to Shield Pancreatic Cancer Cells from Self-Destruction: University of Texas M. D. Anderson Cancer Center Study
March 20, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More